Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

radionuclide therapy

  • You have access
    A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake
    Andrea Galbiati, Aureliano Zana, Matilde Bocci, Jacopo Millul, Abdullah Elsayed, Jacqueline Mock, Dario Neri and Samuele Cazzamalli
    Journal of Nuclear Medicine May 19, 2022, jnumed.122.264036; DOI: https://doi.org/10.2967/jnumed.122.264036
  • You have access
    Safety and efficacy of holmium-166 radioembolization in hepatocellular carcinoma – the HEPAR Primary study
    Margot Thea Maria Reinders, Karel J. van Erpecum, Maarten L. J. Smits, Arthur Johannes Anthonius Theodorus Braat, Joep de Bruijne, Rutger C.G. Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker and Marnix Lam
    Journal of Nuclear Medicine May 19, 2022, jnumed.122.263823; DOI: https://doi.org/10.2967/jnumed.122.263823
  • <sup>90</sup>Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study
    You have access
    90Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study
    Benedikt M. Schaarschmidt, Moritz Wildgruber, Roman Kloeckner, James Nie, Verena Steinle, Arthur J.A.T. Braat, Fabian Lohoefer, Hyun S. Kim, Harald Lahner, Manuel Weber and Jens Theysohn
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 679-685; DOI: https://doi.org/10.2967/jnumed.121.262561
  • You have access
    Outcome of patients with PSMA-PET/CT screen failure by VISION criteria and treated with 177Lu-PSMA therapy: a multicenter retrospective analysis
    Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine April 14, 2022, jnumed.121.263441; DOI: https://doi.org/10.2967/jnumed.121.263441
  • You have access
    A pipeline for automated voxel dosimetry: application in patients with multi-SPECT/CT imaging following 177Lu peptide receptor radionuclide therapy
    Yuni K. Dewaraja, David M Mirando, Avery Peterson, Jeremy Niedbala, John D Millet, Justin K Mikell, Kirk Frey, Ka Kit Wong, Scott Wilderman and Aaron S Nelson
    Journal of Nuclear Medicine April 14, 2022, jnumed.121.263738; DOI: https://doi.org/10.2967/jnumed.121.263738
  • You have access
    89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice
    Linda N Broer, Daan G Knapen, Frans Valentijn Suurs, Ingrid Moen, Danique Giesen, Stijn J H Waaijer, Baard Indrevoll, Christine Ellingsen, Alexander Kristian, Alan S Cuthbertson, Derk-Jan A de Groot, Patricia E Cole, Elisabeth G.E. de Vries, Urs B Hagemann and Marjolijn N Lub - de Hooge
    Journal of Nuclear Medicine April 14, 2022, jnumed.121.263079; DOI: https://doi.org/10.2967/jnumed.121.263079
  • Open Access
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study
    Andrei Gafita, Isabel Rauscher, Manuel Weber, Boris Hadaschik, Hui Wang, Wesley Robert Armstrong, Robert Tauber, Tristan R. Grogan, Johannes Czernin, Matthew B. Rettig, Ken Herrmann, Jeremie Calais, Wolfgang A. Weber, Matthias Benz, Wolfgang P. Fendler and Matthias Eiber
    Journal of Nuclear Medicine April 14, 2022, jnumed.121.263072; DOI: https://doi.org/10.2967/jnumed.121.263072
  • You have access
    The Importance of Training, Accreditation and Guidelines for The Practice of Theranostics: The Australian Perspective
    Sze Ting Lee, Louise M Emmett, David A. Pattison, Michael S Hofman, Dale L. Bailey, Melissa Latter, Roslyn J Francis and Andrew Scott
    Journal of Nuclear Medicine April 7, 2022, jnumed.122.263996; DOI: https://doi.org/10.2967/jnumed.122.263996
  • You have access
    Safety of peptide receptor radionuclide therapy with 177Lutetium DOTATATE in neuroendocrine tumour patients with chronic kidney disease
    Shahad Alsadik, Gopinath Gnanasegaran, Louhai Chen, Dalvinder Mandair, Christos Toumpanakis, Martyn Caplin and Shaunak Navalkissoor
    Journal of Nuclear Medicine February 24, 2022, jnumed.121.263056; DOI: https://doi.org/10.2967/jnumed.121.263056
  • Open Access
    mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis
    Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, Ismaheel Lawal, Otto Knoesen, Johncy Mahapane, Cindy Davis, Amanda Mdlophane, Alex Maes, Kgomotso Mokoala, Kgomotso Mathabe, Christophe Van de Wiele and Alfred Morgenstern
    Journal of Nuclear Medicine February 17, 2022, jnumed.121.263618; DOI: https://doi.org/10.2967/jnumed.121.263618

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire